Regular reassessment of bleeding risk using the HAS-BLED score reduces bleeding outcomes in a prospective cohort: A report from the mAFA II clinical trial extension

Authors
Category Primary study
JournalEuropean Heart Journal
Year 2020
This article has no abstract
Epistemonikos ID: 9f7cc699ea3e839a9fc5ac53d9b770f0ff5757ef
First added on: Feb 12, 2025